Cardiac sympathetic responses to acute vasodilation: Normal ventricular function versus congestive heart failure

Circulation

Volumn 94, Issue 12, 1996, Pages 3161-3167

  Newton, Gary E ^a   Parker, John D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

failure; heart; norepinephrine; vasodilation

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDRALAZINE; ISOSORBIDE DINITRATE; NITROPRUSSIDE SODIUM; NORADRENALIN; TRITIUM;

ADULT; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; FEMALE; HEART CATHETERIZATION; HEART VENTRICLE; HEART VENTRICULOGRAPHY; HEMODYNAMICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LUNG ARTERY PRESSURE; MALE; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SCINTILLATION SPECTROMETRY; SYMPATHETIC TONE; VASODILATATION;

EID: 0030455671     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3161     Document Type: Article

References (42)

1. Leimbach WN, Wallin BG, Victor RG, Aylward PE, Sundlof G, Mark AL. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913-919.
2. Hasking GJ, Esler MD, Jennings GJ, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
3. Cohn JN, Levine TB, Olivari MT, Garberg V, Tura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
4. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
5. 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β,-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
6. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992;85: 790-804.
7. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med. 1991;325:618-624.
8. Olivari MT, Levine TB, Cohn JN. Abnormal neurohumoral response to nitroprusside infusion in congestive heart failure. J Am Coll Cardiol. 1983;2:411-417.
9. Levine TB, Francis GS, Goldsmith SR, Cohn JN. The neurohumoral and hemodynamic response to orthostatic tilt in patients with congestive heart failure. Circulation. 1983;67:1070-1075.
10. Mohanty PK, Arrowood JA, Ellenbogen KA, Thames MD. Neuro-hormonal and hemodynamic effects of lower body negative pressure in patients with congestive heart failure. Am Heart J. 1989;118: 78-85.
11. Ferguson DW, Abboud FM, Mark AL. Selective impairment of baro-reflex-mediated vasoconstrictor responses in patients with ventricular dysfunction. Circulation. 1984;69:451-460.
12. Creager MA, Creager SJ. Arterial baroreflex regulation of blood pressure in patients with congestive heart failure. J Am Coll Cardiol. 1994;23:401-405.
13. Middlekauff HR, Nitzsche EU, Hamilton MA, Schelbert HR, Fona-row GC, Moriguchi JD, Hage A, Saleh S, Gibbs G. Evidence for preserved cardiopulmonary baroreflex control of renal cortical blood flow in humans with advanced heart failure: a positron emission to-mography study. Circulation. 1995;92:395-401.
14. Ferguson DW, Berg WJ, Roach PJ, Oren RM, Mark AL. Effects of heart failure on baroreflex control of sympathetic neural activity. Am J Cardiol. 1992;69:523-531.
15. Grassi G, Seravalle G, Cattaneo BM, Lanfranchi A, Vailati S, Gian-nattasio C, Del Bo A, Sala C, Bolla GB, Pozzi M, Mancia G. Sympathetic activation and loss of reflex sympathetic control in mild congestive heart failure. Circulation. 1995;92:3206-3211.
16. Sopher SM, Smith ML, Eckberg DL, Fritsch JM, Dibner-Dunlap ME. Autonomic pathophysiology in heart failure: carotid baroreceptor-cardiac reflexes. Am J Physiol. 1990;259:H689-H696.
17. Dibner-Dunlap ME, Smith ML, Kinugawa T, Thames MD. Enala-prilat augments arterial and cardiopulmonary baroreflex control of sympathetic nerve activity in patients with heart failure. J Am Coll Cardiol. 1996;27:358-364.
18. Kingwell BA, Thompson JM, Kaye DM, McPherson GA, Jennings GL, Esler MD. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90: 234-240.
19. Kaye DM, Lambert GW, Lefkovits J, Morris M, Jennings G, Esler MD. Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol. 1994;23:570-578.
20. Newton GE, Tong JS, Schofield AM, Baines AD, Floras JS, Parker JD. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure. J Am Coll Cardiol. 1996;28:155-161.
21. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol. 1984;247:E21-E28.
22. Ganz W, Tamura K, Marcus HS, Donoso R, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971;44:181-195.
23. 1-selective and nonselective β-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure. Circulation. 1996;94:353-358.
24. Johnson JM, Rowell LB, Neiderberger M, Eisman MM. Human splanchnic and forearm vasoconstrictor responses to reductions of right atrial and aortic pressures. Circ Res. 1974;34:515-524.
25. Takeshita A, Mark AL, Eckberg DL, Abboud FM. Effect of central venous pressure on arterial baroreflex control of heart rate. Am J Physiol. 1979;236:H42-H47.
26. Honda T, Ninomiya I, Azumi T. Cardiac sympathetic nerve activity and catecholamine kinetics in cat hearts. Am J Physiol. 1987;252: H879-H885.
27. Ninomiya I, Nishimaru N, Irisawa H. Sympathetic nerve activity to the spleen, kidney, and heart in response to baroreceptor input. Am J Physiol. 1971;221:1346-1351.
28. Glick G. Importance of the carotid sinus baroreceptors in the regulation of myocardial performance. J Clin Invest. 1971;50:1116-1123.
29. Vatner SF, Pagini M, Rutherford JD, Millard RW, Manders WT. Effects of nitroglycerin on cardiac function and regional blood flow distribution in conscious dogs. Am J Physiol. 1978;234:H244-H252.
30. Starling MR, Montgomery DG, Mancini GBJ, Walsh RA. Load independence of the rate of isovolumic relaxation in man. Circulation. 1987;76:1274-1281.
31. Varma SK, Owen RM, Smucker ML, Feldman MD. Is t a preload-independent measure of isovolumetric relaxation? Circulation. 1989; 80:1757-1765.
32. Masking GJ, Esler MD, Jennings GL, Dewar E, Lambert G. Norepinephrine spillover to plasma during steady-state supine bicycle exercise: comparison of patients with congestive heart failure and normal subjects. Circulation. 1988;78:516-521.
33. Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor sensitivity in experimental heart failure. Circulation. 1990;81:1959-1966.
34. Dibner-Dunlap ME, Thames MD. Baroreflex control of renal sympathetic nerve activity is preserved in heart failure despite reduced arterial baroreflex sensitivity. Circ Res. 1989;65:1526-1535.
35. Wang W, Chen JS, Zucker IH. Carotid sinus baroreceptor reflex in dogs with experimental heart failure. Circ Res. 1991;68:1294-1301.
36. Davis D, Sinoway LI, Robison J, Minotti JR, Day FP, Baily R, Zelis R. Norepinephrine kinetics during orthostatic stress in congestive heart failure. Circ Res. 1987;61(suppl I):I-87-I-90.
37. Baily RG, Prophet SA, Shenberger JS, Zelis R, Sinoway LI. Direct neurohumoral evidence for isolated sympathetic nervous system activation to skeletal muscle in response to cardiopulmonary baroreceptor unloading. Circ Res. 1990;66:1720-1728.
38. Yamaguchi N, De Champlain J, Nadeau R. Correlation between the response of the heart to sympathetic stimulation and the release of endogenous catecholamines into the coronary sinus of the dog. Circ Res. 1975;36:662-668.
39. Goldstein DS, Brush JE, Eisenhofer G, Stull R, Esler M. In vivo measurement of neuronal uptake of norepinephrine in the human heart. Circulation. 1988;78:41-48.
40. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vaso-constriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994;75:1073-1077.
41. Rossen JD, Oskarsson H, Stenberg RG, Braun P, Talman CL, Win-niford MD. Simultaneous measurement of coronary flow reserve by left anterior descending coronary artery Doppler and great cardiac vein thermodilution methods. J Am Coll Cardiol. 1992;20:402-407.
42. Mathey DG, Chatterjee K, Tyberg JV, Lekven J, Brundage B, Parmeley WW. Coronary sinus reflux: a source of error in the measurement of thermodilution coronary sinus flow. Circulation. 1971;57: 778-786.